atorvastatin has been researched along with Anemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Fujisawa, S; Fukatsu, Y; Sugimoto, Y | 1 |
Masajtis-Zagajewska, A; Nowicki, M | 1 |
Mittal, A; Nand, N | 1 |
Chiang, CK; Hsu, SP; Huang, JW; Hung, KY; Pai, MF; Peng, YS; Wu, KD; Yang, SY | 1 |
Clark, AL; Cleland, JG; Coletta, AP; Loh, PH; Tin, L | 1 |
3 trial(s) available for atorvastatin and Anemia
Article | Year |
---|---|
Effect of atorvastatin on iron metabolism regulation in patients with chronic kidney disease - a randomized double blind crossover study.
Topics: Aged; Anemia; Atorvastatin; Cross-Over Studies; Double-Blind Method; Female; Glomerular Filtration Rate; GPI-Linked Proteins; Hemochromatosis Protein; Hemoglobins; Hepcidins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Male; Metabolic Networks and Pathways; Middle Aged; Renal Insufficiency, Chronic; Treatment Outcome | 2018 |
Evaluation of Effect of Statins on Erythropoietin Resistance in Patients of Chronic Kidney Disease on Maintenance Haemodialysis.
Topics: Adult; Anemia; Atorvastatin; Erythropoietin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Renal Dialysis; Renal Insufficiency, Chronic | 2018 |
Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: role of anti-inflammation effects.
Topics: Aged; Anemia; Atorvastatin; Drug Synergism; Erythropoietin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Prospective Studies; Pyrroles; Recombinant Proteins; Renal Dialysis; Tumor Necrosis Factor-alpha | 2009 |
2 other study(ies) available for atorvastatin and Anemia
Article | Year |
---|---|
[Atorvastatin-induced anemia accompanied by elevated serum LDH levels].
Topics: Aged; Anemia; Atorvastatin; Cholesterol, LDL; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Simvastatin | 2020 |
Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902.
Topics: Anemia; Atorvastatin; Cardiology; Clinical Trials as Topic; Congresses as Topic; Darbepoetin alfa; Diuretics; Erythropoietin; Europe; Exercise Tolerance; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Societies, Medical; Xanthines | 2006 |